IRF8 and neoplasm: In melanoma and breast cancer, IRF-8 has been shown to exhibit tumor-suppressive functions by enhancing anti-tumor immunity through the promotion of effective T cell responses for producing of pro-inflammatory cytokines and the differentiation and activation of myeloid-derived immune cells for recognizing and eliminating tumor cells [22, 25].